Crack cocaine half-life
This entry uses the short parent-cocaine decline observed after smoked administration and keeps it separate from benzoylecgonine and other metabolites.
Every curve begins at 100%. No dose or measured body concentration is assumed.
X-axis: elapsed time. Y-axis: modeled percentage of the relative starting point remaining. This is a mathematical visualization, not a personal concentration estimate.
Crack cocaine: evidence and interpretation notes
What the representative value means
This entry uses the short parent-cocaine decline observed after smoked administration and keeps it separate from benzoylecgonine and other metabolites. The route label is essential; “crack” is not a different active molecule with an independent universal half-life.
The visual model centers on Crack cocaine at 1 hours. Nothing in the calculation adjusts for dose history, organ function, interactions, tolerance, or a study’s sampling method.
Crack cocaine is a route/form entry, so the molecule and metabolite context still trace back to cocaine. The curve does not estimate intoxication, craving, cardiovascular risk, or testing windows.
What each source contributes
- PubChem: Crack cocaine. This identity record confirms names and compound identity and does not supply a human half-life.
- Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. This human pharmacokinetic record adds measured route, analyte, and population context and does not become a universal result.
For Crack cocaine, the numerical model is tied most closely to Cocaine disposition in saliva following intravenous, intranasal, and smoked administration. As a human pharmacokinetic record, it adds measured route, analyte, and population context; it does not become a universal result.
Why there is no range on the chart
This profile plots 1 hours for Crack cocaine without adding an unsourced high-low band. A single supported center is more honest than manufacturing a range from unrelated routes, populations, or formulations.
InterpretationReading the curve and its category context
Reading this curve
HalfLifeDB uses 1 h as a representative input for Crack cocaine. In the simplified model, about 0.0% remains after 24 hours and about 3% remains after five half-lives, or roughly 5 h.
This is a short curve. The modeled amount changes noticeably over the same day, while effects, metabolites, and safety questions can still follow a different timeline. The curve is relative: it does not estimate a person's measured concentration, effects, impairment, or time to clearance.
cocaine form context
Cocaine-form entries need route and formulation context because absorption and peak timing can change dramatically while metabolite interpretation remains important.
- The curve does not estimate impairment, cardiovascular risk, or testing outcomes.
- Metabolites may be more relevant than the parent compound for some questions.
- Route-specific source details should be checked before comparison.
ComparisonTimeline checkpoints and nearby profiles
Crack cocaine timeline checkpoints
| Elapsed time | Modeled remaining | Reading note |
|---|---|---|
| 6 h | 1.56% | Low modeled remainder, not a clearance guarantee |
| 12 h | 0.02% | Low modeled remainder, not a clearance guarantee |
| 24 h | 0.00% | Low modeled remainder, not a clearance guarantee |
| 2.0 days | 0.00% | Low modeled remainder, not a clearance guarantee |
| 3.0 days | 0.00% | Low modeled remainder, not a clearance guarantee |
Nearby profiles by half-life
These entries sit near Crack cocaine within the cocaine form group when sorted by representative half-life. That makes them curve comparisons, not statements about equal potency, effects, or risk.
No nearby published profiles are available in this category.
EvidencePharmacokinetic inputs and source trail
Pharmacokinetics at a glance
| Representative half-life | 1 h |
|---|---|
| Curve type | Normalized, first-order decline |
Selection note: This entry uses the short parent-cocaine decline observed after smoked administration and keeps it separate from benzoylecgonine and other metabolites. The route label is essential; “crack” is not a different active molecule with an independent universal half-life.
Sources and evidence context
A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.
- Identity record PubChem Compound Summary: Crack cocaine.Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
- Research abstract PubMed: Cocaine disposition in saliva following intravenous, intranasal, and smoked administration.Direct pharmacokinetic context. Population, route, formulation, analyte, and sampling duration still determine how broadly the result can be applied.
BoundariesWhat this page cannot answer and where to continue
What this page does not answer
- It does not estimate impairment, intoxication, or fitness to drive.
- It does not predict urine, blood, saliva, or hair test results.
- It does not model repeated exposure, tolerance, withdrawal, or interactions.
- It does not replace clinician, pharmacist, toxicologist, or emergency guidance.
Continue with context
- All substance profiles
- Browse the cocaine-form group
- Compare this curve
- Clearance and volume of distribution
- Bioavailability, route, and formulation
- Active metabolites and parent compounds
- First-order vs nonlinear kinetics
- Detection windows vs half-life
- Reading labels and source quality
Read the medical disclaimer, methodology, and research standards before using the model for comparison.